Guocai Q. Wang
State Key Laboratory Of Bioactive Molecules And Druggability Assessment
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
ROS-driven mitophagy arrest mediates the anti-glioblastoma activity of Molephantin.
Journal: Autophagy
Published: May 06, 2026
EM2, a Natural Product MST1/2 Kinase Activator, Suppresses Non-Small Cell Lung Cancer via Hippo Pathway Activation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 11, 2025
AI-identified CD133-targeting natural compounds demonstrate differential anti-tumor effects and mechanisms in pan-cancer models.
Journal: EMBO molecular medicine
Published: February 28, 2025
Advances, challenges and future applications of liver organoids in experimental regenerative medicine.
Journal: Frontiers in medicine
Published: November 05, 2024
Structurally novel tryptamine-derived alkaloids from the seeds of Peganum harmala and their antiviral activities against respiratory syncytial virus.
Journal: Chinese journal of natural medicines
Published: September 23, 2024
New acylphloroglucinol-sesquiterpenoid adducts with antiviral activities from Dryopteris atrata.
Journal: Chinese journal of natural medicines
Published: December 26, 2023
Discovery of cyperenoic acid as a potent and novel entry inhibitor of influenza A virus.
Journal: Antiviral research
Published: October 12, 2023
A Novel Aniline Derivative from Peganum harmala L. Promoted Apoptosis via Activating PI3K/AKT/mTOR-Mediated Autophagy in Non-Small Cell Lung Cancer Cells.
Journal: International journal of molecular sciences
Published: June 21, 2023
Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 18, 2023
Targeting VCP potentiates immune checkpoint therapy for colorectal cancer.
Journal: Cell reports
Published: January 11, 2023
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
Journal: Nature communications
Published: November 01, 2022
Last Updated: 09/26/2026